The efficiency adjustment cuts introduced in the 2026 MPFS are based on false assumptions. The American Society of Nuclear Cardiology and other medical societies are pushing back.

The new guidance, the first of its kind, focuses on the importance of making a prompt diagnosis and providing care as quickly as possible. While some PE patients with mild cases can be discharged early, others may require an immediate catheter-based intervention or surgery.

A U.S. District Court in Texas ruled that the agency overstepped its regulatory authority in passing the 2024 Biden-era reporting requirement, which would require stakeholders to spend more than 100 hours filling out a long form to give the agency more oversight of transactions. 

Emerging research suggests that the early postpartum period may represent a critical window for influencing a woman's long-term cardiovascular health. 

Nearly 40 healthcare organizations signed a letter in support of the bipartisan legislation, noting that Medicare's “efficiency adjustment” decreases reimbursement during a challenging time for physicians.

Researchers found that their advanced machine learning model consistently outperformed current risk stratification techniques.

The Evolut Low Risk trial has been one of cardiology’s most closely watched studies for years now. For the first five years after treatment, TAVR and SAVR were associated with comparable outcomes when treating low-risk patients. In this new six-year update, however, TAVR was linked to a heightened risk of reintervention not seen with SAVR. 

U.S. Radiology departments navigating CT market challenges—supply disruptions and rising demand for contrast and delivery—need reliable partners. Hear Bayer leads explain how Bayer helps provide steady supply and innovations to support CT imaging and patient care.